BiotechTube
Home/Lucina Biotherapeutics/Chris Chavez, PhD
CC

Chris Chavez, PhD

Cofounder and CEO

Lucina Biotherapeutics

Therapeutic Areas

OphthalmologyAging-related Disorders

Lucina Biotherapeutics Pipeline

DrugIndicationPhase
LUC-101Dry Age-Related Macular Degeneration (AMD)IND-Enabling
LUC-201Undisclosed (likely aging-related disorders)Preclinical

Leadership Team at Lucina Biotherapeutics

ME
Marty Emanuele, PhD, MBA
Cofounder and Executive Chairman
JG
Jeanette Grant, PhD
Cofounder and COO
DB
David Bingaman, DMV, PhD
Chief Development Officer
View full Lucina Biotherapeutics profile